Ischemic stroke. Cerebral infarction
Conditions
Interventions
Intervention 1: Control group took placebo pills daily with the same appearance and packaging. Intervention 2: Intervention group treated with oral allopurinol produced by Jalinous Pharmaceutical Comp
Placebo
Treatment - Drugs
Control group took placebo pills daily with the same appearance and packaging
Intervention group treated with oral allopurinol produced by Jalinous Pharmaceutical Company (200 mg daily) for 3 months
Sponsors
Vice chancellor for research,Tabriz University of medical sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients diagnosed with acute cerebral ischemic stroke (within the first day that caused symptoms), age more than 18 years old; high serum uric acid on admission and hospitalized in Imam Reza university hospital,Tabriz, Iran. Exclusion criteria: severe post stroke disability; current morbidness disability and any condition that could interfere with prognosis evaluation such as: chronic disease of kidney, liver or hematology and cancers. In addition, gout symptoms and the history of recent treatment with allopurinol were considered as exclusion criteria.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional status after stroke. Timepoint: At hospitalization(0), and after 3 months(1). Method of measurement: Functional status score based on NIHSS(National institute of health stroke scale). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ali Akbar Taheraghdam
Imam Reza Hospital
Outcome results
None listed